STAT 3 as a Target for Cancer Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|9|834-843

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.9, 2008-04, pp. : 834-843

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

STAT proteins as novel targets for cancer drug discovery

By Turkson James  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 5, 2004-10 ,pp. : 409-422

Informa Healthcare

Access to resources Recommend Favorite

New Approaches to Target the Androgen Receptor and STAT3 for Prostate Cancer Treatments

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-03 ,pp. : 395-400

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand-directed profiling: applications to target drug discovery in cancer

By Staquicini Fernanda I   Pasqualini Renata   Arap Wadih  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 51-59

Informa Healthcare

Access to resources Recommend Favorite

The role of murine models of prostate cancer in drug target discovery and validation

By Ahmad Imran   Sansom Owen J   Leung Hing Y  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 8, 2009-08 ,pp. : 879-888

Informa Healthcare

Access to resources Recommend Favorite

USP7: Target Validation and Drug Discovery for Cancer Therapy

By  

Medicinal Chemistry, Vol. 14, Iss. 1, 2018-01 ,pp. : 3-18

Bentham Science Publishers

Access to resources Recommend Favorite